Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Loss of p53 Is a Marker of Progression in Plasma Cell Neoplasias and Is a Negative Prognostic Factor in Relapsed Disease.

Soledad Molnar, MD, Victor J Jimenez Zepeda, Scott Van Wier, Esteban Braggio, Jonathan Keats, Michael Kuehl, Tammy Price-Troska, Greg Ahmann, Rachel Rempel, Kim Henderson, MD, S. Vincent Rajkumar, MD, Philip. R Greipp, MD, Daniel Auclair, John Carpten, Angela Baker, Keith Stewart, MD, P. Leif Bergsagel, MD, Wee Joo Chng, MD, Rafael Fonseca, MD

Blood (2008) 112 (11): 1663.

https://doi.org/10.1182/blood.V112.11.1663.1663

Published: 2008

Journal Articles

Association of High Levels of Free Light Chain and the Presence of Igh Translocations in Multiple Myeloma and Prognostic Implications.

Shaji Kumar, Lijun Zhang, Angela Dispenzieri, Scott Van Wier, Jerry Katzmann, Melissa Snyder, Emily Blood, Roberta DeGoey, Kim Henderson, Arthur Bradwell, Robert Kyle, Philip Greipp, S. Vincent Rajkumar, Rafael Fonseca

Blood (2008) 112 (11): 1677.

https://doi.org/10.1182/blood.V112.11.1677.1677

Published: 2008

Journal Articles

Activation of MYC Pathway Is a Unifying Pathological Event in the Progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma (MM).

Wee J. Chng, MD, Marta Chesi, PhD, Tammy Price-Troska, Greg Ahmann, Kim Henderson, Philip Greipp, MD, Robert Kyle, MD, S. Vincent Rajkumar, MD, Morie Gertz, MD, Rafael Fonseca, MD, P. Leif Bergsagel, MD

Blood (2007) 110 (11): 241.

https://doi.org/10.1182/blood.V110.11.241.241

Published: 2007

Journal Articles

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

Wee-Joo Chng, MD, Angela Baker, PhD, Travis Henry, PhD, Tammy Price-Troska, Scott Van Wier, Tae-Hoon Chung, PhD, Kim Henderson, Gregory Ahmann, Martha Lacy, MD, Angela Dispenzieri, MD, Morie Abraham Gertz, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2006) 108 (11): 113.

https://doi.org/10.1182/blood.V108.11.113.113

Published: 2006

Journal Articles

Promiscuous Mutations Frequently Activate the Non-Canonical NFkB Pathway in Multiple Myeloma (MM).

Blood (2006) 108 (11): 109.

https://doi.org/10.1182/blood.V108.11.109.109

Published: 2006

Journal Articles

Clinical implication of centrosome amplification in plasma cell neoplasm

Wee J. Chng, Greg J. Ahmann, Kim Henderson, Rafael Santana-Davila, Philip R. Greipp, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Shaji Kumar, S. Vincent Rajkumar, John A. Lust, Robert A. Kyle, Steven R. Zeldenrust, Suzanne R. Hayman, Rafael Fonseca

Blood (2006) 107 (9): 3669–3675.

https://doi.org/10.1182/blood-2005-09-3810

Published: 2006

Journal Articles

Genomic Analysis of High Hyperdiploid Acute Lymphoblastic Leukemia and Hyperdiploid Multiple Myeloma Suggests Differential Gene Dosage Effect on Expression and Provide Clues to Preferential Selection of Recurrently Trisomic Chromosomes.

Wee-Joo Chng, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Robert Kyle, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 3006.

https://doi.org/10.1182/blood.V106.11.3006.3006

Published: 2005

Journal Articles

Cancer/Testis Antigen Profiling in Multiple Myeloma Define a Cohort of Patients with Poor Prognosis Regardless of Genetic Subtypes.

Wee-Joo Chng, MD, Natalia Gonzalez-Paz, MD, Shaji Kumar, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Robert Kyle, MD, Philip Greipp, MD, Rafael Fonseca, MD, Peter Leif Bergsagel, MD

Blood (2005) 106 (11): 3381.

https://doi.org/10.1182/blood.V106.11.3381.3381

Published: 2005

Journal Articles

Gene Expression Profiling Identifies 4 Sub-Classes with Distinct Clinical Associations in Hyperdiploid Myeloma.

Wee-Joo Chng, MD, Natalia Gonzalez-Paz, MD, Shaji Kumar, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Robert Kyle, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1537.

https://doi.org/10.1182/blood.V106.11.1537.1537

Published: 2005

Journal Articles

Gene Expression Profiling of Hyperdiploid Multiple Reveal Complex Gene Dosage Effects and an mRNA Translation/Protein Synthesis Signature.

Wee-Joo Chng, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Tae-Hoon Chung, Seungchan Kim, PhD, John Carpten, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Martha Lacy, MD, Robert Kyle, MD, Philip Greipp, MD, Angela Dispenzieri, MD, Peter Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1538.

https://doi.org/10.1182/blood.V106.11.1538.1538

Published: 2005

Journal Articles

Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM).

Wee-Joo Chng, MD, Scott Van Wier, Gregory Ahmann, Rafael Santana-Davila, MD, Syed Jalal, PhD, Rhett Ketterling, MD, Peter Leif Bergsagel, MD, Marta Chesi, PhD, Mike Trendle, MD, Martin Oken, MD, Emily Blood, Kim Henderson, Robert Kyle, MD, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1539.

https://doi.org/10.1182/blood.V106.11.1539.1539

Published: 2005

Journal Articles

Low Level Amplification (Duplication) of 1q21 in Myeloma and Prognosis; the Role of CKS1B.

Rafael Fonseca, MD, Scott Van Wier, Wee-Joo Chng, MD, Rhett Ketterling, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Peter Leif Bergsagel, MD, S. Vincent Rajkumar, MD, Philip Greipp, MD, Mark Litzow, MD, Shaji Kumar, MD, Natalia Gonzalez-Paz, MD, Kim Henderson, Gregory Ahmann, Morie Gertz, MD

Blood (2005) 106 (11): 624.

https://doi.org/10.1182/blood.V106.11.624.624

Published: 2005

Journal Articles

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS

Wee Joo Chng, Scott A. Van Wier, Gregory J. Ahmann, Jerry M. Winkler, Syed M. Jalal, Peter Leif Bergsagel, Marta Chesi, Mike C. Trendle, Martin M. Oken, Emily Blood, Kim Henderson, Rafael Santana-Dávila, Robert A. Kyle, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Philip R. Greipp, Rafael Fonseca

Blood (2005) 106 (6): 2156–2161.

https://doi.org/10.1182/blood-2005-02-0761

Published: 2005

NARROW

Loss of p53 Is a Marker of Progression in Plasma Cell Neoplasias and Is a Negative Prognostic Factor in Relapsed Disease.

Association of High Levels of Free Light Chain and the Presence of Igh Translocations in Multiple Myeloma and Prognostic Implications.

Activation of MYC Pathway Is a Unifying Pathological Event in the Progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma (MM).

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

Promiscuous Mutations Frequently Activate the Non-Canonical NFkB Pathway in Multiple Myeloma (MM).

Clinical implication of centrosome amplification in plasma cell neoplasm

Genomic Analysis of High Hyperdiploid Acute Lymphoblastic Leukemia and Hyperdiploid Multiple Myeloma Suggests Differential Gene Dosage Effect on Expression and Provide Clues to Preferential Selection of Recurrently Trisomic Chromosomes.

Cancer/Testis Antigen Profiling in Multiple Myeloma Define a Cohort of Patients with Poor Prognosis Regardless of Genetic Subtypes.

Gene Expression Profiling Identifies 4 Sub-Classes with Distinct Clinical Associations in Hyperdiploid Myeloma.

Gene Expression Profiling of Hyperdiploid Multiple Reveal Complex Gene Dosage Effects and an mRNA Translation/Protein Synthesis Signature.

Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM).

Low Level Amplification (Duplication) of 1q21 in Myeloma and Prognosis; the Role of CKS1B.

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only